On Friday, Dexcom Inc (NASDAQ: DXCM) was -1.52% drop from the session before settling in for the closing price of $78.92. A 52-week range for DXCM has been $62.34 – $142.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 28.80% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 12.24%. With a float of $385.55 million, this company’s outstanding shares have now reached $390.60 million.
In an organization with 9600 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 61.68%, operating margin of 15.88%, and the pretax margin is 18.81%.
Dexcom Inc (DXCM) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Dexcom Inc stocks. The insider ownership of Dexcom Inc is 1.29%, while institutional ownership is 93.20%. The most recent insider transaction that took place on Nov 20 ’24, was worth 318,275. In this transaction EVP, Chief HR Officer of this company sold 4,259 shares at a rate of $74.73, taking the stock ownership to the 71,192 shares. Before that another transaction happened on Nov 15 ’24, when Company’s EVP, Chief Financal Officer sold 3,500 for $75.51, making the entire transaction worth $264,285. This insider now owns 80,774 shares in total.
Dexcom Inc (DXCM) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.4 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.24% per share during the next fiscal year.
Dexcom Inc (NASDAQ: DXCM) Trading Performance Indicators
You can see what Dexcom Inc (DXCM) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.56. Likewise, its price to free cash flow for the trailing twelve months is 55.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.67, a number that is poised to hit 0.52 in the next quarter and is forecasted to reach 2.04 in one year’s time.
Technical Analysis of Dexcom Inc (DXCM)
Let’s dig in a bit further. During the last 5-days, its volume was 3.21 million. That was inferior than the volume of 3.91 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 67.47%. Additionally, its Average True Range was 2.47.
During the past 100 days, Dexcom Inc’s (DXCM) raw stochastic average was set at 28.48%, which indicates a significant decrease from 53.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.38% in the past 14 days, which was lower than the 91.04% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $72.33, while its 200-day Moving Average is $99.67. However, in the short run, Dexcom Inc’s stock first resistance to watch stands at $79.04. Second resistance stands at $80.35. The third major resistance level sits at $81.21. If the price goes on to break the first support level at $76.87, it is likely to go to the next support level at $76.01. Assuming the price breaks the second support level, the third support level stands at $74.70.
Dexcom Inc (NASDAQ: DXCM) Key Stats
There are 390,595K outstanding shares of the company, which has a market capitalization of 29.90 billion. As of now, sales total 3,622 M while income totals 541,500 K. Its latest quarter income was 994,200 K while its last quarter net income were 134,600 K.